ClinConnect ClinConnect Logo
Search / Trial NCT02925780

12 Month Follow up in Vivo Icon Study on Fluorotic Teeth

Launched by DMG DENTAL MATERIAL GESELLSCHAFT MBH · Oct 4, 2016

Trial Information

Current as of May 06, 2025

Withdrawn

Keywords

Enamel Defects Fluorosis Icon Resin Infiltration

ClinConnect Summary

Dental fluorosis is an endemic public health concern that develops if infants are subjected to excessive amounts of fluoride during enamel formation. Anatomopathologically, dental fluorosis presents itself as a hypermineralized surface layer and subsurface hypomineralization involving the external third of the thickness of the enamel, which is equivalent to early carious lesions. In addition, fluorosis features a number of clinical changes in the enamel surface, ranging from the appearance of thin white lines up to severe structural defects, thereby compromising overall esthetics, which som...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Questionable, Very mild, and Mild (Dean's Index) dental fluorosis as well as TF scale grades 1, 2, and 3 of the upper anterior teeth.
  • Parents of children who accept and commit to the informed consent letter collaborate with the study taking their children to each of the scheduled follow ups.
  • Exclusion Criteria:
  • Teeth without fluorosis.
  • Teeth with hypoplasia.
  • Teeth with incipient caries lesions observed at gingival level and differentiated by the Presence of plaque.
  • Teeth previously restored or with aesthetic corrective treatments
  • Teeth with endodontic treatment.
  • Patients with low or questionable hygiene.
  • Malnourished patients or that have some underlying disease.
  • Teeth with less than two thirds of its visible crown.
  • Children that have less than six teeth in their oral cavity.
  • Allergic reaction to methylmethacrylate.

About Dmg Dental Material Gesellschaft Mbh

dmg dental material gesellschaft mbh is a leading manufacturer and innovator in dental materials, dedicated to advancing oral healthcare through research and development. With a commitment to quality and excellence, dmg specializes in a wide range of dental products, including composites, adhesives, and impression materials, designed to enhance clinical outcomes and improve patient experiences. The company actively engages in clinical trials to evaluate the efficacy and safety of its products, ensuring compliance with the highest industry standards and contributing to the advancement of dental technology. Through collaboration with dental professionals and researchers, dmg aims to deliver cutting-edge solutions that meet the evolving needs of the dental community.

Locations

Patients applied

0 patients applied

Trial Officials

Ana Armas Vega

Principal Investigator

Universidad Internacional del Ecuador

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials